Literature DB >> 17199284

Highly diastereoselective synthesis of nucleoside adducts from the carcinogenic benzo[a]pyrene diol epoxide and a computational analysis.

Mahesh K Lakshman1, John C Keeler, Felix N Ngassa, John H Hilmer, Padmanava Pradhan, Barbara Zajc, Kathryn A Thomasson.   

Abstract

A diastereoselective synthesis of the nucleoside adducts corresponding to a cis ring-opening of the carcinogen (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BaP DE-2) by 2'-deoxyadenosine and 2'-deoxyguanosine is described. The key intermediate (+/-)-10alpha-amino-7beta,8alpha,9alpha-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene was synthesized by a highly diastereoselective dihydroxylation wherein phenylboronic acid was a water surrogate. The resulting boronate ester was converted to a tetraol derivative in which two of the four hydroxyl groups (trans 7, 8) were protected as benzoate esters while the remaining two (cis 9, 10) were free. The cis glycol entity was then subjected to a reaction with 1-chlorocarbonyl-1-methylethylacetate to yield an intermediate chloro monoacetoxy dibenzoate. Displacement of the halide with azide, complete cleavage of the esters, and catalytic reduction of the azide yielded the requisite amino triol. Fluoride displacement from appropriately protected nucleoside derivatives, 6-fluoropurine 2'-deoxyribonucleoside and 2-fluoro-2'-deoxyinosine, by the amino triol then yielded diastereomeric pairs of diol epoxide-adducted 2'-deoxyadenosine (dA) and 2'-deoxyguanosine (dG) nucleosides. Small aliquots of these adducts were separated for characterization purposes. The present approach provides the first diastereoselective synthesis of the cis adducts of BaP DE-2 with 2'-deoxyguanosine as well as the first synthesis of both dA and dG adducts from a common intermediate. An informative analysis of the 1H NMR spectra of the cis adducts synthesized and comparisons to the trans adducts are reported. To gain insight into the diastereoselectivity in the key dihydroxylation step, a computational analysis, including molecular mechanics (MMFF94) and semiempirical AM1 geometry optimizations, yielded results that are in fairly good agreement with the experimental observations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17199284      PMCID: PMC2659345          DOI: 10.1021/ja063902u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  45 in total

Review 1.  Factors that influence the mutagenic patterns of DNA adducts from chemical carcinogens.

Authors:  K Y Seo; S A Jelinsky; E L Loechler
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

Review 2.  Toward an understanding of the role of DNA adduct conformation in defining mutagenic mechanism based on studies of the major adduct (formed at N(2)-dG) of the potent environmental carcinogen, benzo[a]pyrene.

Authors:  R Kozack; K Y Seo; S A Jelinsky; E L Loechler
Journal:  Mutat Res       Date:  2000-05-30       Impact factor: 2.433

Review 3.  DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides.

Authors:  J Szeliga; A Dipple
Journal:  Chem Res Toxicol       Date:  1998-01       Impact factor: 3.739

4.  Resonance assignments of non-exchangeable protons in B type DNA oligomers, an overview.

Authors:  F J van de Ven; C W Hilbers
Journal:  Nucleic Acids Res       Date:  1988-07-11       Impact factor: 16.971

5.  Evaluation of the enantiomeric resolution of 7,8-dihydroxy-7,8-dihydrobenzo[a]-pyrene and its 6-fluoro and 6-bromo derivatives on polysaccharide-derived stationary phases.

Authors:  Barbara Zajc; Rok Grahek; Andrej Kocijan; Mahesh K Lakshman; Janez Kosmrlj; Jure Lah
Journal:  J Org Chem       Date:  2003-04-18       Impact factor: 4.354

6.  Base sequence effects in bending induced by bulky carcinogen-DNA adducts: experimental and computational analysis.

Authors:  Q Ruan; P Zhuang; S Li; R Perlow; A R Srinivasan; X J Lu; S Broyde; W K Olson; N E Geacintov
Journal:  Biochemistry       Date:  2001-09-04       Impact factor: 3.162

7.  Site-specific modification of the human N-ras proto-oncogene with each diol epoxide metabolite of benzo[a]pyrene and thermal denaturation studies of the adducted duplexes.

Authors:  S Chaturvedi; M K Lakshman
Journal:  Carcinogenesis       Date:  1996-12       Impact factor: 4.944

8.  Intercalation of the (1R,2S,3R,4S)-N6-[1-(1,2,3,4-tetrahydro-2,3,4-trihydroxybenz[a]anthracenyl)]-2'-deoxyadenosyl adduct in the N-ras codon 61 sequence: DNA sequence effects.

Authors:  Z Li; P J Tamura; A S Wilkinson; C M Harris; T M Harris; M P Stone
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

9.  NMR evidence for syn-anti interconversion of a trans opened (10R)-dA adduct of benzo[a]pyrene (7S,8R)-diol (9R,10S)-epoxide in a DNA duplex.

Authors:  D E Volk; J S Rice; B A Luxon; H J Yeh; C Liang; G Xie; J M Sayer; D M Jerina; D G Gorenstein
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

10.  Palladium-catalyzed synthesis of carcinogenic polycyclic aromatic hydrocarbon epoxide-nucleoside adducts: the first amination of a chloro nucleoside.

Authors:  Mahesh K Lakshman; Padmaja Gunda
Journal:  Org Lett       Date:  2003-01-09       Impact factor: 6.005

View more
  3 in total

1.  Highly diastereoselective synthesis of modified nucleosides via an asymmetric multicomponent reaction.

Authors:  Arun K Ghosh; Jorden Kass
Journal:  Chem Commun (Camb)       Date:  2010-01-25       Impact factor: 6.222

2.  Synthesis of Mitomycin C and decarbamoylmitomycin C N6 deoxyadenosine-adducts.

Authors:  Maggie Zheng; Seokjin Hwang; Timothy Snyder; Jake Aquilina; Gloria Proni; Manuel M Paz; Padmanava Pradhan; Shu-Yuan Cheng; Elise Champeil
Journal:  Bioorg Chem       Date:  2019-09-12       Impact factor: 5.275

3.  Noncovalent interactions of a benzo[a]pyrene diol epoxide with DNA base pairs: insight into the formation of adducts of (+)-BaP DE-2 with DNA.

Authors:  Jacqueline C Hargis; Henry F Schaefer; K N Houk; Steven E Wheeler
Journal:  J Phys Chem A       Date:  2010-02-04       Impact factor: 2.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.